CD19 CAR T-Cell Therapy Promising for Patients With Primary CNS Lymphoma
Researchers sought to determine whether CD19-directed CAR T-cell therapy would be effective for patients with primary CNS lymphoma.
Researchers sought to determine whether CD19-directed CAR T-cell therapy would be effective for patients with primary CNS lymphoma.
Researchers sought to determine whether patients with PNH would have improvements in their quality of life taking eculizumab or ravulizumab.
Researchers sought to determine whether grant funding, even small grants, would be beneficial for research into SCD.
Researchers sought to determine whether daratumumab with lenalidomide and dexamethasone would improve survival in patients with newly diagnosed multiple myeloma.
Researchers sought to determine the degree mothers understand sickle cell disease and the trait of the family from a diagnosed child.
Researchers sought to determine whether combination therapy with indatuximab ravtansine would have clinical activity in patients with relapsed/refractory multiple myeloma.
Researchers sought to determine the effect of CEBPA-bZip mutations on disease prognosis for patients with acute myeloid leukemia.
Researchers sought to determine whether von Willebrand factor may be a potential target for therapies to address thrombotic complications in patients with COVID-19.
Researchers sought to determine whether lenalidomide combined with miR-22 mimics may sensitize multiple myeloma cells to help overcome drug resistance.
Researchers sought to determine whether mobile health technology may play a helpful role in the management of hemophilia.